This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

LTC Donald S. Burke, MC; MAJ Robert R. Redfield, MC
Walter Reed Army Institute of Research Washington, DC

JAMA. 1986;256(3):347.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

As part of the US Army quality assurance program for human T-cell lymphotropic virus type III (HTLV-III) testing, we recently sent identical proficiency panels to five large commercial firms that offered HTLV-III Western blot testing on a fee-for-service basis. Each panel consisted of 15 samples from healthy, low-risk adults whose serum was repeatedly negative for HTLV-III antibodies and five samples from HTLVIII-infected (culture-documented) patients. By Western blot analysis, all five positive samples produced definite, but not strong, bands at 41 kilodaltons (kd) and other molecular weights characteristic of HTLV-III proteins.¹

Scores ranged from 85% to 100% accuracy (Table). Four of the five laboratories reported at least one falsepositive test result. The six falsepositive results were all on different normal specimens, suggesting that the errors were due to technique and not to intrinsic biologic properties of the specimens. There was a substantial range of clarity of the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?